Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QD Didanosine Regimen vs Standard BID Regimen in HIV
NCT00256828Phase 4Completed
- Sponsor
- Clinical Trial Agency of HIV Study Group
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of didanosine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Clinical Trial Agency of HIV Study Group. Primary endpoint: Percentage of patients with HIV-RNA levels < 50 c/ml at 48 weeks. Started Jun 2004; status: completed.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00256828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256828.